For embolism patients, clot-busting drug is worth risk, study suggests
When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result? Based on new findings researchers are answering that question in no uncertain terms. View full story